1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one
C20H22ClF3N2OS — CID 156514473
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one
1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one (PubChem CID 156514473) has the molecular formula C20H22ClF3N2OS and a molecular weight of 430.92 g/mol. Its IUPAC name is 1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one.
Molecular Properties
| Compound Name | 1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one |
|---|---|
| PubChem CID | 156514473 |
| Molecular Formula | C20H22ClF3N2OS |
| Molecular Weight | 430.92 g/mol |
| Exact Mass | 430.11 |
| IUPAC Name | 1-[4-[5-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl]-2-methyl-3-(5-methylthiophen-2-yl)propan-1-one |
| SMILES | Cc1ccc(CC(C)C(=O)N2CCN(c3cc(Cl)ccc3C(F)(F)F)CC2)s1 |
| InChI | InChI=1S/C20H22ClF3N2OS/c1-13(11-16-5-3-14(2)28-16)19(27)26-9-7-25(8-10-26)18-12-15(21)4-6-17(18)20(22,23)24/h3-6,12-13H,7-11H2,1-2H3 |
| InChIKey | LBCDVKWRXTUITE-UHFFFAOYSA-N |
| XLogP | 5.26 |
| TPSA | 23.55 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.92 |
| LogP ≤ 5 | 5.26 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156514473 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.